Mosaic Therapeutics

Mosaic Therapeutics is owned by Syncona.

Syncona is one of the...

• FTSE 350.

Syncona is a company listed under the stock ticker SYNC (GB).

Syncona has a direct presence in 3 countries.

Syncona has 13 subsidiaries including Achilles Therapeutics, Anaveon and Autolus Therapeutics.

They are in:

• Biotechnology86%
• Holding7%
• Other7%

Acquisition, funding and merger involving Syncona.

• Syncona has announced the acquisition of Beacon Therapeutics  (posted on October 28 2022).

View the org chart displaying its 4 main executives

Most searched biographies at Mosaic Therapeutics

• Brian Gladsden, Chief Executive Officer
• Amy Emery, Head of Biology
• Mathew Garnett, Director of Strategy

Create your alert
to follow the executive moves at Mosaic Therapeutics.

Syncona has 1,826 competitors including IQVIA (United States (USA)), Siemens Healthineers (Germany) and Saint Francis Health System (United States (USA)).

Popular M&A news in Healthcare

• KKR has announced the acquisition of Healthium  (posted on May 9 2024).
• Rad AI has just announced a $50 Million fundraising (posted on May 7 2024).
• Midi Health has just announced a $60 Million fundraising (posted on April 29 2024).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Ralph De La Torre - Chairman and Chief Executive Officer at Steward Health Care
• Paulo Junqueira Moll - Chief Executive Officer at Rede D'Or Sao Luiz

Learn more about the Healthcare industry >

Press releases by Mosaic Therapeutics

• Mosaic Therapeutics Closes $28m Series A Funding and Appoints Brian Gladsden as CEO
• Mosaic Tx

Social media about Mosaic Therapeutics

• Mosaic Therapeutics on Wikipedia, Google News & Yahoo Finance
• Mosaic Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Grahame Mckenzie

Call Mosaic Therapeutics at +44 778 ...

View the org chart

Register to receive your alert

Report an error